Literature DB >> 2035918

Effects of topical administration of timolol maleate on intraocular pressure and pupil size in cats.

D A Wilkie1, C A Latimer.   

Abstract

Effects of topical administration of a single dose of timolol maleate, a nonselective beta-adrenergic blocking agent, on intraocular pressure (IOP) and pupil diameter were evaluated in the normotensive eyes of 10 clinically normal cats over 12 hours. Mean (+/- SEM) normal IOP was 17.1 (+/- 1.1) mm of Hg and diurnal fluctuation was observed, with the highest IOP seen in the evening. Mean (+/- SEM) normal pupil diameter was 10.1 (+/- 0.5) mm. Topical treatment with 0.5% timolol resulted in reduction of IOP in treated and nontreated eyes. This effect was time-dependent and was first observed at 6 hours after treatment. Mean reduction of IOP was 22.3% in the treated eye and 16.3% in the nontreated eye. The treated eye had reduced pupil diameter at 30 minutes after treatment, and miosis persisted throughout the 12 hours of the study. Mean reduction of pupil diameter was 38.7%. A contralateral effect on pupil diameter was not seen in the nontreated eye. Topical administration of timolol maleate results in a reduction of IOP in treated and contralateral eyes, which supports the use of timolol for treatment of glaucoma in cats. In addition, the treated eye becomes miotic. This effect may indicate beta-adrenergic inhibition or alpha-adrenergic activation of the iris sphincter muscle. beta-Adrenergic blockade would then result in miosis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2035918

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  9 in total

Review 1.  Feline glaucoma--a comprehensive review.

Authors:  Gillian J McLellan; Paul E Miller
Journal:  Vet Ophthalmol       Date:  2011-09       Impact factor: 1.644

2.  Effect of topical latanoprost 0.005% on intraocular pressure and pupil diameter in normal and glaucomatous cats.

Authors:  Jessica E McDonald; Julie A Kiland; Paul L Kaufman; Ellison Bentley; N Matthew Ellinwood; Gillian J McLellan
Journal:  Vet Ophthalmol       Date:  2015-07-16       Impact factor: 1.644

3.  Effects of brimonidine 0.2%-timolol 0.5% fixed-combination therapy for glaucoma.

Authors:  Sung Woo Cho; Joon Mo Kim; Ki Ho Park; Chul Young Choi
Journal:  Jpn J Ophthalmol       Date:  2010-11-05       Impact factor: 2.447

4.  The effect of dorzolamide 2% on circadian intraocular pressure in cats with primary congenital glaucoma.

Authors:  Kelly J Sigle; Gabriel Camaño-Garcia; Alicia L Carriquiry; Daniel M Betts; Markus H Kuehn; Gillian J McLellan
Journal:  Vet Ophthalmol       Date:  2011-09       Impact factor: 1.644

5.  Effects of brimonidine timolol fixed combination therapy on anterior ocular segment configuration.

Authors:  Joon Mo Kim; Ki Ho Park; Chan Yun Kim; Hwang Ki Kim; Tae-Woo Kim; Mo Sae Kim
Journal:  Jpn J Ophthalmol       Date:  2011-06-17       Impact factor: 2.447

6.  Effect of timolol maleate gel-forming solution on intraocular pressure, pupil diameter, and heart rate in normal and glaucomatous cats.

Authors:  Julie A Kiland; Andrea M Voss; Gillian J McLellan
Journal:  Vet Ophthalmol       Date:  2016-03-18       Impact factor: 1.644

7.  Dysregulation of the autonomous nervous system in patients with temporomandibular disorder: a pupillometric study.

Authors:  Annalisa Monaco; Ruggero Cattaneo; Luca Mesin; Irma Ciarrocchi; Fabrizio Sgolastra; Davide Pietropaoli
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

8.  Effects of 0.5% Timolol Maleate Ophthalmic Solution on Heart Rate and Selected Echocardiographic Indices in Apparently Healthy Cats.

Authors:  C T Gunther-Harrington; E S Ontiveros; T E Hodge; L C Visser; J A Stern
Journal:  J Vet Intern Med       Date:  2016-03-10       Impact factor: 3.333

9.  The effects of topical dorzolamide 2% and brinzolamide 1%, either alone or combined with timolol 0.5%, on intraocular pressure, pupil diameter, and heart rate in healthy cats.

Authors:  Inge J M Slenter; Sylvia C Djajadiningrat-Laanen; Daphne J Elders; Reinoud de Gee; Linda E Koele; Loes W Vermeer; Michael H Boevé
Journal:  Vet Ophthalmol       Date:  2019-05-17       Impact factor: 1.644

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.